Skip to main content

Metformin News

Metformin Added to Insulin Not Beneficial for T2D in Pregnancy

TUESDAY, Dec. 12, 2023 – For pregnant women with type 2 diabetes, the addition of metformin to insulin does not affect composite adverse neonatal outcomes, according to a study published in the Dec....

Metformin May Help Young Patients With Bipolar Disorder Avoid Weight Gain

TUESDAY, Oct. 31, 2023 – Taking the drug metformin – typically used for type 2 diabetes – can help counter weight gain in young people who are taking medication for bipolar disorder, according to a n...

Dementia Incidence Increased With Termination of Metformin

FRIDAY, Oct. 27, 2023 – Terminating metformin treatment is associated with an increased incidence of dementia, according to a study published online Oct. 25 in JAMA Network Open. Scott C. Zimmerman,...

Have Diabetes? Quitting Metformin Could Take Toll on Your Brain

THURSDAY, Oct. 26, 2023 -- Millions of people with diabetes take the drug metformin to control their blood sugar levels.  Meant to be taken for the long term, new research now suggests that stopping i...

Early Metformin May Not Aid Gestational Diabetes

THURSDAY, Oct. 5, 2023 – Early metformin initiation in women with gestational diabetes does not reduce the occurrence of the combination of a fasting glucose level ≥5.1 mmol/L at gestation weeks 32 o...

Could Metformin Help Seniors Bounce Back After Surgery?

FRIDAY, July 28, 2023 – The diabetes drug metformin might also benefit older patients after an injury or illness, a small study suggests. Researchers found that metformin – a drug that has been...

Diabetes Medications: Choosing Which Ones Are Best for You

WEDNESDAY, July 5, 2023 – You have been diagnosed with type 2 diabetes. What are your medication options? That depends on what type of diabetes you have and what risk factors you carry. In type 2...

Outpatient Metformin Treatment Reduces Incidence of Long COVID

MONDAY, June 12, 2023 – Outpatient treatment with metformin reduces the incidence of long COVID, especially when started within three days of symptom onset, according to a study published online...

Diabetes Med Metformin Might Help Prevent Long COVID

FRIDAY, June 9, 2023 – A safe, generic diabetes pill can help people avoid long COVID, a new clinical trial shows. Metformin cut the risk of long COVID by about 40% for patients who received a...

Head-to-Head Study Finds Which Diabetes Meds Are Best for the Heart

TUESDAY, May 9, 2023 – There are many medications for type 2 diabetes, but one class may stand out for protecting the heart, a new study suggests. The study, of thousands of U.S. veterans with...

FDA Medwatch Alert: Viona Issues Consumer Level Voluntary Nationwide Recall of Metformin HCl Extended- Release Tablets, USP 750 mg Due to Detection of NDMA Impurity

January 12, 2022 – Cranford, New Jersey, Viona Pharmaceuticals Inc., is voluntarily recalling twenty-three (23) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg at the consumer...

FDA Medwatch Alert: Viona Issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg Due to the Detection of NDMA Impurity

December 28, 2021 – Cranford, New Jersey, Viona Pharmaceuticals Inc., is voluntarily recalling thirty three (33) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail l...

FDA Medwatch Alert: Viona Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg Due to the Detection of NDMA Impurity

Viona Pharmaceuticals Inc., is voluntarily recalling 2 (two) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail level. The 2 (two) lots of Metformin Hydrochloride...

FDA Medwatch Alert: Nostrum Laboratories, Inc. Expands Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

January 25, 2021 – Kansas City, Missouri, Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets)...

FDA Medwatch Alert: Nostrum Laboratories, Inc. Expands Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

January 4, 2021 – Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) to the consumer level....

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Diabetes, Type 2, Insulin Resistance, Polycystic Ovary Syndrome, Female Infertility

Related drug support groups

Glucophage

Metformin patient information at Drugs.com